Recently, Fabrice Gritti, Principal Consulting Scientist at Waters, was featured in the Analytical Scientist’s annual Power List, which recognizes talent, ingenuity and leadership across all corners of analytical science on a global scale. We sat… Read more >
On October 2, 2019, Waters proudly opened our new Swedish head office and laboratory in the House of Innovations, located in the center of Campus Solna next to Karolinska Institutet. The new facility features an… Read more >
As a science-based organization, STEM education is of the utmost importance to Waters. This blog highlights the excitement of its partnership with Junior Achievement, one of the world’s largest youth-serving NGOs that prepares young people for employment and entrepreneurship.
In late January, I traveled to WCBP (Well Characterized Biological Products), an industry conference that is hosted every year by the CASSS organization. It serves as a forum that brings together biopharmaceutical industry professionals and… Read more >
Waters’ legacy of purposeful innovation continues with the recently introduced RenataDX Screening System, a flow-injection tandem mass spectrometry system for high-throughput analysis of extracted dried blood spots and other physiological matrices.
There are two primary multi-attribute monitoring (MAM) assay choices for biologic development and QC: subunit protein mass analysis and peptide mapping by LC-MS. Here we explore how peptide mapping LC-MS MAM workflows are being used.
Two MAM approaches for biotherapeutic analysis are being implemented today; one focused on the analysis of monoclonal antibody (mAb) subunits, and the other focused on the analysis of peptides from a protein digest (peptide mapping workflow). Both have their advantages and disadvantages. Here, we explore MAM for mAb subunit analysis.
The improvements in LC-MS technology under GxP compliant-ready informatics for biopharmaceutical analysis has prepared the industry to expand the role of MS technologies beyond product characterization toward monitoring product and process quality attributes.
Determining whether the cyanobacteria present in a water body are producing toxins requires laboratory testing. However, detection of microcystins is a challenging problem for water testing laboratories.
How to design an analytical workflow to screen for extractables and leachables The safety of pharmaceuticals, cosmetics, and foodstuffs may be compromised by chemical compounds in the various types of packaging and food contact materials… Read more >
